# Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy

Study · id `cardio:ct-nct02129985` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02129985](<https://clinicaltrials.gov/study/NCT02129985>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02129985

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT02129985. Randomized; no masking; primary purpose treatment. Start 2014-02 (registry gives no type); primary completion 2015-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT02129985, source copy `cardio:ctgov-nct02129985-2014-05-02`, retrieved 2026-10-26)
- Start date: 2014-02 (registry gives no type) (ClinicalTrials.gov record NCT02129985, source copy `cardio:ctgov-nct02129985-2014-05-02`, retrieved 2026-10-26)
- Primary completion: 2015-06 (anticipated) (ClinicalTrials.gov record NCT02129985, source copy `cardio:ctgov-nct02129985-2014-05-02`, retrieved 2026-10-26)
- Completion: 2015-09 (anticipated) (ClinicalTrials.gov record NCT02129985, source copy `cardio:ctgov-nct02129985-2014-05-02`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02129985, source copy `cardio:ctgov-nct02129985-2014-05-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02129985-2014-05-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy
- Acronym: T2DMRS
- Condition: Type 2 Diabetes
- Intervention (Drug): Exenatide
- Intervention (Drug): Metformin
- Lead sponsor: xiaolong zhao
- Lead sponsor class: OTHER
- Collaborator: Shanghai Zhongshan Hospital
- Collaborator class: OTHER
- Collaborator: The third people's Hospital Affiliated to Shanghai Jiao Tong University
- Collaborator class: UNKNOWN
- Collaborator: Second Affiliated Hospital of Soochow University
- Collaborator class: OTHER
- Collaborator: The First Hospital of Guiyang Medical college
- Collaborator class: UNKNOWN
- Collaborator: Fuling Central Hospital of Chongqing City
- Collaborator class: OTHER
- Collaborator: Taizhou Hospital
- Collaborator class: OTHER
- Collaborator: Shanghai Pudong New Area Gongli Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as a collaborator: Shanghai Zhongshan Hospital (`cardio:org-shanghai-zhongshan-hospital`)
- Registry lists this organization as a collaborator: Second Affiliated Hospital of Soochow University (`cardio:org-second-affiliated-hospital-of-soochow-university`)
- Registry lists this organization as a collaborator: Taizhou Hospital (`cardio:org-taizhou-hospital`)

## Provenance

Content hash: 6df9fe033696ed7970e24ef327c3b37969aba054735adc27ba362ef259eb23e4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
